CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
43.30
-1.43 (-3.20%)
At close: Dec 5, 2025, 4:00 PM EST
43.67
+0.37 (0.85%)
After-hours: Dec 5, 2025, 6:24 PM EST
CG Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,493 | 2,183 | - | - | - |
| Enterprise Value | 2,820 | 1,643 | - | - | - |
| Last Close Price | 43.30 | 28.68 | - | - | - |
| PS Ratio | 1606.64 | 1916.94 | - | - | - |
| PB Ratio | 4.93 | 2.98 | - | - | - |
| P/TBV Ratio | 5.19 | 2.98 | - | - | - |
| EV/Sales Ratio | 1297.07 | 1442.48 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0 | 0.00 | 0.13 | 0.38 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Quick Ratio | 22.30 | 34.76 | 13.17 | 9.32 | 8.97 |
| Current Ratio | 22.79 | 35.30 | 13.62 | 9.54 | 9.78 |
| Return on Equity (ROE) | -24.74% | -19.18% | -31.36% | -42.85% | - |
| Return on Assets (ROA) | -17.56% | -15.02% | -19.97% | -21.34% | - |
| Return on Capital (ROIC) | -18.28% | -15.60% | -21.24% | -22.42% | - |
| Return on Capital Employed (ROCE) | -25.80% | -15.60% | -30.00% | -26.60% | -23.90% |
| Earnings Yield | -4.34% | -4.03% | - | - | - |
| FCF Yield | -3.35% | -3.62% | - | - | - |
| Buyback Yield / Dilution | -60.24% | -1343.03% | -15.77% | -2.48% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.